The more an EU (European Union) national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Sunday) and published simultaneously in the leading cancer journal Annals of Oncology [2]...
Breast cancer: 'critical gaps' found in research
10/01/2013
A new study published in the journal Breast Cancer Research has identified 10 "critical gaps" that exist in the research of the disease, which could see the loss of hundreds of thousands of lives if not addressed urgently...
Improved survival in breast cancer through early treatment of chest lymph nodes
10/01/2013
Giving radiation therapy to the lymph nodes located behind the breast bone and above the collar bone to patients with early breast cancer improves overall survival without increasing side effects...
New imaging technique could cut down on false positives in breast cancer screening
10/01/2013
A joint BYU-Utah research team is developing a new breast cancer screening technique that has the potential to reduce false positives, and, possibly, minimize the need for invasive biopsies...
Lung cancer drug doing well in smoker trial
9/30/2013
Early results of a trial testing the safety of a new type of drug that helps the immune system attack cancer cells is showing promising results in lung cancer patients, especially in those who are smokers or former smokers. The experimental drug, called MPDL3280A (made by Roche), is being tested in patients with non-small cell lung cancer (NSCLC)...
LEO Pharma has announced the completion of the Phase III FIELD Study 1 - the largest[1-3] ever, one year evaluation of field treatment with ingenol mebutate gel for actinic keratosis (AK) after initial cryosurgery of individual AK lesions, compared to cryosurgery followed by a vehicle gel...
Lung cancer drug doing well in smoker trial
9/30/2013
Early results of a trial testing the safety of a new type of drug that helps the immune system attack cancer cells is showing promising results in lung cancer patients, especially in those who are smokers or former smokers. The experimental drug, called MPDL3280A (made by Roche), is being tested in patients with non-small cell lung cancer (NSCLC)...
Breast cancer spread: clues found in molecular switch
9/30/2013
Using state of the art technology, researchers at the University of Copenhagen in Denmark have pinpointed molecular mechanisms that they suspect play an important role in breast cancer cell growth and spread (metastasis)...
Commercial urine test for prostate cancer available
9/30/2013
A new urine test for prostate cancer that measures minute fragments of RNA is now commercially available to men nationwide through the University of Michigan MLabs...
Novel tool developed by colorectal surgeons for measuring quality and outcomes
9/30/2013
Since the publication in 2000 of a report titled "To Err is Human" by the Institute of Medicine which called for a reduction in preventable medical errors, there has been an increasing demand for making improvements in the quality and measurement of health care outcomes...